Novartis Ag (NVSEF) Gross Profit Growth (5y) (2014 - 2025)

Novartis Ag (NVSEF) Gross Profit Growth (5y) (2014 - 2025) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag - - -

Historic Data

Download Data
DateValue
Jun 30, 2025 7.04%
Jun 30, 2024 2.39%
Dec 31, 2023 79.67%
Jun 30, 2023 -1.31%
Mar 31, 2023 1,155.94%
Dec 31, 2022 -314.36%
Sep 30, 2022 313.12%
Jun 30, 2022 2.53%
Mar 31, 2022 -45.76%
Dec 31, 2021 -78.51%
Sep 30, 2021 -50.00%
Jun 30, 2021 -89.47%
Mar 31, 2021 11,498.46%
Dec 31, 2020 -51.17%
Sep 30, 2020 190,212.56%
Jun 30, 2020 2,476.92%
Mar 31, 2020 1,086.73%
Jun 30, 2019 2,840.52%
Mar 31, 2019 706.62%
Dec 31, 2018 1,607.84%